Exact Mass: 821.4925155999999

Exact Mass Matches: 821.4925155999999

Found 17 metabolites which its exact mass value is equals to given mass value 821.4925155999999, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

3-<4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)>oxy>olean-12-en-28-oic acid|3-{[O-beta-D-galactopyranosyl-(1[*]4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)]oxy}olean-12-en-28-oic acid

C44H71NO13 (821.4925155999999)

lotoidoside E|oleanolic acid 3-O-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranoside

C44H71NO13 (821.4925155999999)

3-O-[beta-D-Galactopyranosyl-(1?4)-2-acetamido-2-deoxy-beta-D-glucopyranside]-3beta-3-Hydroxy-12-oleanen-28-oic acid

C44H71NO13 (821.4925155999999)

Tacrolimus

Tacrolimus monohydrate

C44H71NO13 (821.4925155999999)

C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C146638 - Calcineurin Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D016559 - Tacrolimus COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tacrolimus monohydrate (FK506 monohydrate), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex and inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].

C44H69NO10.H2O

C44H71NO13 (821.4925155999999)

Hex2Cer 16:3;2O/16:4

C44H71NO13 (821.4925155999999)

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

C44H71NO13 (821.4925155999999)

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C44H71NO13 (821.4925155999999)

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C44H71NO13 (821.4925155999999)

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C44H71NO13 (821.4925155999999)

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

C44H71NO13 (821.4925155999999)

(4as,6as,6br,8ar,10s,12ar,12br,14br)-10-{[(2r,3r,4r,5s,6r)-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14br)-10-{[(2r,3r,4r,5s,6r)-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C44H71NO13 (821.4925155999999)

10-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl}oxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl}oxy)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C44H71NO13 (821.4925155999999)